PATENT CLAIM ANALYSIS

Application Number: 16007880
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "221000"]

Abstract:
Methods are provided herein for selectively killing senescent cells and for treating senescence-associated diseases and disorders by administering a senolytic agent. Senescence-associated diseases and disorders treatable by the methods using the senolytic agents described herein include cardiovascular diseases and disorders associated with or caused by arteriosclerosis, such as atherosclerosis; idiopathic pulmonary fibrosis; chronic obstructive pulmonary disease; osteoarthritis; senescence-associated ophthalmic diseases and disorders; and senescence-associated dermatological diseases and disorders.

Claim (Index 13):
The unit dose according to  claim 1 , formulated such that a single unit dose of the pharmaceutical composition administered to the subject during the treatment period is effective in relieving the symptoms of the pulmonary condition in the lung during the therapeutic period.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 94.0
- Lexical Diversity: 1.58333
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15955542', '15956613', '15827539', '15647688', '15467129']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9005838448981697
- 35 USC 102 Novelty (BERT): 0.6579722560473188
- Combined Prediction Score: 0.8763226860130846
- Mean Citation Score: 782.6381399999997
- Max Citation Score: 864.57825
- Similarity Product: 589.587777102381

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test